<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <atom:link href="https://feeds.megaphone.fm/RSUSA4490966169" rel="self" type="application/rss+xml"/>
    <title>Scrip Podcasts</title>
    <link>https://insights.citeline.com/scrip/</link>
    <language>en</language>
    <copyright>All rights reserved</copyright>
    <description>Scrip delivers fresh, expert‑driven audio insights on biopharma and the life sciences – fast, clear and essential. Tune in for the latest trends, deals and breakthroughs with shows like Scrip’s Five Must‑Know Things, your weekly roundup of top industry news, and the Scrip Awards Podcast, highlighting the leaders and innovations shaping the field. Stay informed and stay ahead with new episodes every week.</description>
    <image>
      <url>https://megaphone.imgix.net/podcasts/bc226ce2-31a8-11f1-b5b6-abbed618de63/image/67754bdbd76837a5b24db2d47aad85aa.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress</url>
      <title>Scrip Podcasts</title>
      <link>https://insights.citeline.com/scrip/</link>
    </image>
    <itunes:type>episodic</itunes:type>
    <itunes:subtitle></itunes:subtitle>
    <itunes:author>Norstella</itunes:author>
    <itunes:summary>Scrip delivers fresh, expert‑driven audio insights on biopharma and the life sciences – fast, clear and essential. Tune in for the latest trends, deals and breakthroughs with shows like Scrip’s Five Must‑Know Things, your weekly roundup of top industry news, and the Scrip Awards Podcast, highlighting the leaders and innovations shaping the field. Stay informed and stay ahead with new episodes every week.</itunes:summary>
    <content:encoded>
      <![CDATA[<p>Scrip delivers fresh, expert‑driven audio insights on biopharma and the life sciences – fast, clear and essential. Tune in for the latest trends, deals and breakthroughs with shows like Scrip’s <em>Five Must‑Know Things</em>, your weekly roundup of top industry news, and the <em>Scrip Awards Podcast</em>, highlighting the leaders and innovations shaping the field. Stay informed and stay ahead with new episodes every week.</p>]]>
    </content:encoded>
    <itunes:owner>
      <itunes:name>Norstella</itunes:name>
      <itunes:email>webpubs@citeline.com</itunes:email>
    </itunes:owner>
    <itunes:image href="https://megaphone.imgix.net/podcasts/bc226ce2-31a8-11f1-b5b6-abbed618de63/image/67754bdbd76837a5b24db2d47aad85aa.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
    <itunes:category text="Business">
    </itunes:category>
    <item>
      <title>Podcast: Europe’s Evolving Role in Global Clinical Trials</title>
      <description>As global clinical development strategies evolve, Europe is emerging as a critical hub for scientific innovation, operational agility, and patient recruitment — reshaping its role in the future of clinical trials.

In this episode, Scott Davis, Vice President of Clinical Services at Novotech, joins Andrew Warmington from Citeline to explore how sponsors are rethinking Europe’s place in global development programs amid shifting geopolitical, regulatory, and operational dynamics.</description>
      <pubDate>Mon, 18 May 2026 11:09:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Norstella</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/fd55e122-52a9-11f1-8d5a-c35f16fdf6c9/image/301841c11f4cdca4b79ca521d7e40c94.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>As global clinical development strategies evolve, Europe is emerging as a critical hub for scientific innovation, operational agility, and patient recruitment — reshaping its role in the future of clinical trials.

In this episode, Scott Davis, Vice President of Clinical Services at Novotech, joins Andrew Warmington from Citeline to explore how sponsors are rethinking Europe’s place in global development programs amid shifting geopolitical, regulatory, and operational dynamics.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>As global clinical development strategies evolve, Europe is emerging as a critical hub for scientific innovation, operational agility, and patient recruitment — reshaping its role in the future of clinical trials.</p>
<p>In this episode, Scott Davis, Vice President of Clinical Services at Novotech, joins Andrew Warmington from Citeline to explore how sponsors are rethinking Europe’s place in global development programs amid shifting geopolitical, regulatory, and operational dynamics.</p>]]>
      </content:encoded>
      <itunes:duration>625</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[fd55e122-52a9-11f1-8d5a-c35f16fdf6c9]]></guid>
      <enclosure url="https://traffic.megaphone.fm/RSUSA5127529709.mp3" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Scrip Deals Podcast: An Interview With Jeremy Levin</title>
      <description>Ovid Therapeutics Chairman Jeremy Levin talks with Scrip about how the US should view its biotech sector as a strategic national asset and urges the venture capital sector to place more emphasis on supporting early and innovative science.</description>
      <pubDate>Thu, 14 May 2026 02:43:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Norstella</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/a3b6bd62-4f3e-11f1-99f0-e3349ac764bb/image/d2079efb4cd62d0735bf8a1d4749ca8a.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Ovid Therapeutics Chairman Jeremy Levin talks with Scrip about how the US should view its biotech sector as a strategic national asset and urges the venture capital sector to place more emphasis on supporting early and innovative science.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Ovid Therapeutics Chairman Jeremy Levin talks with Scrip about how the US should view its biotech sector as a strategic national asset and urges the venture capital sector to place more emphasis on supporting early and innovative science.

</p>]]>
      </content:encoded>
      <itunes:duration>2779</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[a3b6bd62-4f3e-11f1-99f0-e3349ac764bb]]></guid>
      <enclosure url="https://traffic.megaphone.fm/RSUSA6411160107.mp3" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>The Scrip Awards Podcast - Call For Entries 2026, New AI Category, Triana Interview</title>
      <description></description>
      <pubDate>Tue, 12 May 2026 14:38:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Norstella</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/4cb5a5ca-4e10-11f1-b27f-ebeecd774cbc/image/67754bdbd76837a5b24db2d47aad85aa.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary></itunes:summary>
      <content:encoded>
        <![CDATA[]]>
      </content:encoded>
      <itunes:duration>1500</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[4cb5a5ca-4e10-11f1-b27f-ebeecd774cbc]]></guid>
      <enclosure url="https://traffic.megaphone.fm/RSUSA8159191285.mp3" length="0" type="audio/mpeg"/>
    </item>
  </channel>
</rss>
